Navigation Links
Propidium Iodide/Antifade Solution from CHEMICON

ProductsPropidium Iodide/Antifade Solution from CHEMICON
Company CHEMICON
Item Propidium Iodide/Antifade Solution
Price $60.00
Description Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI) suspended in Antifade.
Info CHEMICONCHEMICON
CHEMICON International, Inc.
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500
Tech Support: 800-437-7500
Fax Number: 800-437-7502
Web Site: http://www.chemicon.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Propidium Iodide Solution from Calbiochem
2. Propidium Iodide from KPL
3. Propidium Iodide from Calbiochem
4. Propidium Iodide from Calbiochem
5. Propidium iodide; solution (Available only in the U.S.) from Roche Applied Science
6. Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen
7. Propidium Iodide from GeneTex
8. Propidium Iodide Solution [3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide] from CHEMICON
9. Propidium Iodide (1 mg/ml). from BioVision
10. Propidium Iodide Buffer from BioLegend
11. Propidium iodide from Research Organics, Inc.
HybriWell seals securely to a microscope slide surface in seconds to enclose single or multiple specimens in a small reagent volume and eliminate evaporation....
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... Human IgM Assay Kit to address the ... assay for Human IgM that eliminates the ... a simple mix-and-read assay that allows the ... ng/ml in approximately 30 minutes. The Pierce ...
AC input: 230 V...
Biology Products:
(Date:6/8/2015)... SAN DIEGO , June 8, 2015  Trovagene, Inc. ... announced today that clinical data featuring its Precision Cancer Monitoring ... Cancer Markers and Liquid Biopsies conference in San ... the AACR Precision Medicine Series: Integrating Clinical Genomics and ... on June 13-16. "We continue ...
(Date:6/5/2015)... GERMANTOWN, Md. , June 5, 2015  Intrexon ... synthetic biology, today announced that it has determined the ... of all of its 17,830,305 shares of ZIOPHARM Oncology, ... or about June 12, 2015, the distribution date, as ... stock, and on warrants to purchase shares of Intrexon ...
(Date:6/1/2015)... -- According to a new market research ... (Touch-based & Touchless), Application (Consumer Electronics, Automotive, & Others), ... Global Forecast to 2020", published by MarketsandMarkets, the Gesture ... $23.55 Billion by 2020, at a CAGR of 28.23% ... market data T ables and   86   ...
Breaking Biology News(10 mins):Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4
... liver disease, extent of tissue damage depends on the balance ... new liver cells. In a significant minority of people who ... form scars. This can progress to chronic liver disease and ... unable to clean blood or produce vital hormones and clotting ...
... a type of cell that can be activated by tissues ... attack our own molecules, cells and organs, UCSF researchers have ... new strategies for fighting a range of autoimmune diseases ... and cells within us as well as for preventing ...
... CHICAGO A low-calorie diet eliminates insulin dependence ... with type 2 diabetes, according to a study presented ... of North America (RSNA). "Lifestyle interventions may have ... patients," said the study,s lead author, Sebastiaan Hammer, M.D., ...
Cached Biology News:The immune system has protective memory cells, researchers discover 2The immune system has protective memory cells, researchers discover 3Restricted calorie diet improves heart function in obese patients with diabetes 2
(Date:6/26/2015)... (PRWEB) , ... June 26, 2015 , ... ReliantHeart, ... that indicates that from the first implant of the HeartAssist5® LVAD (HA5) to the ... the HA5. , Thrombus that originates in an LVAD is referred to as ...
(Date:6/25/2015)... (PRWEB) , ... June 25, 2015 , ... ... of keynotes speakers for its 2015 National Patient and Family Conference, Providing and ... in Chicago at the Renaissance Chicago O’Hare Suites Hotel, July 24-25, 2015. , ...
(Date:6/25/2015)... June 25, 2015 ... -Authentifizierungsdienstleistungen, führte am 24. und 25. Juni ... am Main das 2. Eco System Partner ... Thema Sicherheit für Patienten in Europa und ...      (Logo: http://photos.prnewswire.com/prnh/20150610/748687) , Vertreter ...
(Date:6/25/2015)... Nev. , June 25, 2015  PDL BioPharma, Inc. ... P. McLaughlin , the company,s president and chief executive officer, ... in London , England.  The fireside chat-style ... June 30, 2015 at 8:30 a.m. BST / 3:30 a.m. ... webcast of the presentation, go to the Company,s website at ...
Breaking Biology Technology:HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 2HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 3Nationally Recognized Brain Tumor Experts to Speak at American Brain Tumor Association Patient and Family Conference 2Symposium zur Richtlinie über gefälschte Arzneimittel - mit Aegate in Deutschland 2Symposium zur Richtlinie über gefälschte Arzneimittel - mit Aegate in Deutschland 3PDL BioPharma to Present at the Nasdaq 32nd Investor Program 2